JOIN US FOR AN INFORMATIONAL WEBINAR RBM – more than risk – Introducing TTM  Wednesday, May 16  | 11 a.m. EDT Register Now > The widespread adoption of a comprehensive risk based monitoring strategy has no doubt been enabling sponsors to minimize the risk associated with a clinical trial. ICH guidelines have made it mandatory to put in place a RBM strategy. However, RBM is no longer simply risk-based monitoring.  Imagine if you could monitor not only risk, but total trial monitoring (TTM). TTM is a larger monitoring strategy that Covance has developed to identify and mediate risk, but TTM looks at the entire trial to help you develop/differentiate an individualized approach to:  Quality-by-Design   Site monitoring  (Interval, variable, adaptive or triggered)  Centralized monitoring (Risk, medical, statistical & holistic data review)  In this webinar you will learn: Why RBM is larger than just risk monitoring How to holistically manage your entire trial using a Total Trial Management approach How to utilize a new RBM approach to meet  ICH GCP guidelines  Join us for an informational webinar, led by our  Executive Director of Central Monitoring,  Michael Walega, as he discusses why Covance has chosen to implement a total trial monitoring approach, and why this is the “new” RBM. You won’t want to miss it! Michael Walega Executive Director of Central Monitoring

Want to reach 150,000+ FierceBiotech subscribers with your own message? Contact aalcover@fiercemarkets.com or call 202-824-5074. About this email: In order to receive FierceBiotech for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceBiotech. Click here to unsubscribe. FierceMarkets, a division of Questex, LLC 1900 L St. NW Suite 400  Washington, DC 20036